Immunohistochemical investigation of selected endothelial markers in pulmonary epithelioid haemangioendothelioma by Ulatowska-Białas, Magdalena et al.
236
POL J PATHOL 2011; 4: 236-240
IMMUNOHISTOCHEMICAL INVESTIGATION OF SELECTED
ENDOTHELIAL MARKERS IN PULMONARY EPITHELIOID
HAEMANGIOENDOTHELIOMA
MAGDALENA BIAŁAS, BOLESŁAW PAPLA, AGNIESZKA BULANDA
Chair and Department of Pathomorphology, Jagiellonian University Medical College, Cracow, Poland
Epithelioid haemangioendothelioma (EH) is a very rare neoplasm. It is assumed that
these tumours derive from vascular endothelial cells. The aim of the study was to
identify the immunohistochemical profile of tumour cells in lung EH. The unique
material consisting of eight cases of lung EH was collected and examined by im-
munohistochemistry with three antibodies: CD-31, CD105, both marking vascu-
lar endothelial cells, and D2-40, marking lymphatic endothelial cells.
In all cases, the cytoplasm of tumour cells showed widespread expression of CD-31.
Reaction with CD-105 antibody gave a positive result mainly in the cytoplasm of
tumour cells located at the periphery of tumours, especially in highly cellular neo-
plasms containing spindle cells. Reaction with D2-40 antibody in most cases was neg-
ative. The presence of a few capillary vessels with positive endothelial cells was re-
vealed in two cases at the periphery of the tumour. Only in one case of a highly cellular
tumour did a small portion of spindle cells show a positive reaction to D2-40.
The above studies confirmed the origin of EH mainly from vascular endothelial cells.
Medications inhibiting vascular endothelial growth factors can be considered as a treat-
ment option for multifocal EH that does not qualify for surgical intervention.
Key words: epithelioid haemangioendothelioma, lung, immunohistochemistry,
anti-vascular treatment.
Introduction
Pulmonary epithelioid haemangioendothelioma (PEH)
is a very rare pulmonary neoplasm. Usually it presents
as multiple foci. A large proportion of these cases involve
young women and a protracted development, usually over
the course of many years, is characteristic [1, 2].
Some authors have divided PEH into a less malignant
and a more malignant variant. The less malignant form
of PEH has a protracted course. Histologically it is a pau-
cicellular neoplasm with extensive areas of hyaline de-
generation and occasional calcifications. Proliferating cells
that are mainly found at the periphery of the neoplasm
have an epithelial appearance and show evidence of vac-
uolization, which corresponds to early vessel formation
(Fig. 1). The more malignant form is a highly cellular
neoplasm with greater atypia and less extensive degen-
erative changes. This form typically follows a more rap-
id course, and pleural infiltration is frequent. Besides ep-
ithelioid cells, spindle cells may also be found in the more
malignant variant of PEH. The presence of these two cell
types in distinctly neighbouring zones can be confirmed
in some neoplasms of the more malignant type (Fig. 2).
The confirmation of the vascular endothelial origins
of PEH presents an opportunity for developing med-
ications targeted and inhibiting vascular endothelial
growth factors.
Materials and methods
The material for the study consisted of eight cases
of PEH. Five patients were female and three male. Six
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of the cases presented as multiple foci; the remaining
two cases were single lesions (Table I). A part of this
material was previously described [2].
The aim of the study was to examine the expression
of endothelial markers in PEH using immunohisto-
chemical methods. Three antibodies were used: CD-31
and CD-105, both marking vascular endothelial cells,
and D2-40, marking lymphatic endothelial cells
(Table II).
The tumour tissue was fixed in formalin, routinely
processed and embedded in paraffin. From these, 4 µm
sections were prepared. A representative section from each
tumour was selected for immunohistochemical investi-
gation. The immunohistochemistry was performed by
the standard method. Briefly, the slides were dewaxed,
rehydrated and incubated in 3% peroxide solution for
10 minutes to block the endogenous peroxidase activ-
ity. Antigen retrieval was carried out by microwaving
in citrate buffer (for CD-105 and D2-40) and EDTA (for
CD-31) for 5 minutes at 700 W, then for 5 minutes at
600 W. The primary antibodies used are listed in Table II.
The Lab-Vision detection system was used.
Table II. Primary antibodies used for immunohistochemical reactions
ANTIBODY MANUFACTURER PRE-TREATMENT DILUTION/INCUBATION TIME DETECTION METHOD
CD-31 DAKO EDTA, pH = 8 1 : 20 (60 min) Lab-Vision
CD-105 Novocastra citrate buffer, pH = 6 1 : 50 (60 min) Lab-Vision
D2-40 Polgen citrate buffer, pH = 6 “ready to use” (30 min) Lab-Vision
Table I. Clinicopathological features of PEH
NO. HISTOLOGICAL NO. SEX AGE CLINICAL FINDINGS CD-31 CD-105 D2-40
1. 1719424 F 34 multiple, bilateral tumours +++ ++ negative
2. 133271/133246 M 57 single tumour in upper left lobe +++ ++ positive in
single spindle
cells
3. 105302 F 19 multiple, bilateral tumours +++ ++ single vessels
positive
4. 1515641 F 44 multiple, bilateral tumours +++ ++ negative
5. 122735 F 65 multiple, bilateral tumours +++ ++ negative
6. 927128 F 18 multiple, bilateral tumours +++ ++ negative
7. 187048 M 33 multiple, bilateral tumours +++ ++ negative
8. 1457626 M 75 single tumour in upper left lobe +++ ++ single vessels
positive
Fig. 1. Pulmonary epithelioid haemangioendothelioma
with extensive hyaline degeneration. The tumour
infiltrates the lung parenchyma without destroying its
structure. (HE stain, 10×)
Fig. 2. Singular tumour infiltrating lung tissue in
a similar manner as Fig. 1. The tumour is highly cellular,
with multiple spindle cells. (HE stain, 10×)
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Results
In all cases, the cell membrane and cytoplasm of tu-
mour cells showed strong and widespread expression
of CD-31. Areas of hyaline change and calcification were
negative for CD-31 (Fig. 3 and 4). The reaction for CD-
105 gave a positive result mainly in the cytoplasm of
neoplastic cells located at the periphery of tumours, es-
pecially in highly cellular neoplasms containing spin-
dle cells, as well as in the endothelium of newly formed
vessels, and was similar to CD-31 (Fig. 5 and 6). Ar-
eas of hyalinization and calcification were negative in
CD-105.
The reaction with D2-40 antibody in most cases was
negative. A few capillary vessels positive for D2-40 at
the periphery of the tumour were present in two cas-
es. We cannot rule out the possibility that some of them
were remnants of normal pulmonary vessels (Fig. 7).
In one case of a highly cellular tumour in a 57-year-
old male (case no. 2) a small portion of spindle cells
showed a positive reaction for D2-40 (Fig. 8).
Discussion
CD-31 antigen is present in the cell membrane of
vascular endothelium in vessels and is characterized by
linear endothelial staining. It promotes endothelial and
leukocyte adhesion in the vascular endothelium. CD-
31 is also present in neoplasms derived from endothelial
cells [3, 4]. Among neoplasms of vascular origin spin-
dle cells found in Kaposi sarcoma represent an excep-
tion, as they do not react with CD-31 antibody [3]. In
addition, megakaryocytes, platelets, cells of myeloid ori-
gin, as well as lymphocytes and their precursors may
show a heterogeneous immunoreaction for CD-31
[4, 5]. Currently, this marker is used for investigating
Fig. 3. Immunohistochemical reaction with CD-31
antibody: positive in majority of neoplastic cells. Areas of
hyaline degeneration are negative. Vacuoles
corresponding to early capillary formation are visible
Fig. 4. Immunohistochemical reaction with CD-31
antibody: part of tumour consisting of multiple spindle
cells positive for CD-31
Figs. 5, 6. Immunohistochemical reaction with CD-105 antibody similar to CD-31 in a biopsy of a classical PEH. Cells
at the periphery of the tumour are strongly positive. Areas of hyaline change are negative
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angiogenesis in neoplastic processes [6]. CD-105 (en-
doglin) belongs to a family of integrins involved with
adhesion receptors found in capillaries, arterioles and
venules. It is preferentially expressed on endothelia of
newly formed vessels, and may thus be used in neoan-
giogenesis investigation. This is in accordance with our
results, as CD-105 positive cells were seen at the pe-
riphery of the lesions, supposedly their growing front.
Reactions for the aforementioned vascular antigens are
thought to be highly specific, staining for certainly more
than reactions for CD-34 and von Willebrand factor
used in the past.
A positive reaction with CD-31 antibody in all cas-
es of PEH neoplasms tested in this study confirms their
relationship to endothelium. Other authors have also
shown the endothelial quality of such neoplasms us-
ing various immunohistochemical and ultrastructur-
al methods [1, 7-9]. This theory is supported by the
epithelial appearance of the tumour cells. However, the
sporadic presence of cytokeratin immunoreactivity that
has been described within cells of some PEH tumours
can be the source of diagnostic errors [3].
D2-40 is an antibody directed against M2A oncofetal
antigen, present on the endothelia of lymphatic ves-
sels [10-13]. The majority of our samples were D2-40
negative; a slight positive reaction in the vessels at the
border of two tumours may have represented residual
lymphatics from the proper lung parenchyma. The sin-
gular case of an anaplastic tumour showed the pres-
ence of spindle cells which were weakly positive for D2-
40. Pleural invasion was also observed in this case. It
is worth mentioning here that PEH neoplasms of the
more malignant type, especially those with pleural in-
filtration, have spindle cells similar to those seen in ma-
lignant mesothelioma. The presence of such cells rep-
resents a potential source of diagnostic confusion,
especially on examination of small pleural biopsies. In-
terestingly, mesothelium also shows D2-40 reactivi-
ty. Furthermore, D2-40 is used for the study and di-
agnostic workup of mesothelium, as well as neoplastic
processes of mesothelial origin [14]. Khan et al. con-
firmed the presence of D2-40 in angiosarcoma and Ka-
posi sarcoma [11].
In conclusion, PEH is a rare, usually multifocal neo-
plasm that may be found in the lungs. Such multiplicity,
along with a good clinical status of those affected, is
the basis of the unsettled debate whether PEH is a pri-
mary, multifocal neoplasm or rather the lung metas-
tasis of tumours located in other organs (mainly the liv-
er). Currently, most authors suggest the metastatic
theory of origin of multiple PEH. The bilateral and mul-
tifocal presence of these tumours in patients excludes
the possibility of surgical intervention. Primary, uni-
focal PEH neoplasms are seldom described – in these
cases the possibility of successful surgical treatment ex-
ists. Taking into account the results of the present study,
and the conclusion that the pulmonary epithelioid hae-
mangioendotheliomas are of blood vessel endothelial
and not lymphatic endothelial origin, medications in-
hibiting vascular endothelial growth factor can be con-
sidered as a treatment option for multifocal PEH that
does not qualify for surgical intervention. A report of
chemotherapy with an anti-VEGF agent (bevacizum-
ab) in primary pleural epithelioid haemangioen-
dothelioma recently appeared [15]. Although that anti-
vascular treatment in the two cases described so far was
not successful, this approach warrants further investi-
gation.
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